Ali̇ İnal
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
-
- IL-33, ST2, and ILC Pathways
Papers in
- Oncology 33
- Lung Cancer Research Studies 10
- Cancer Diagnosis and Treatment 8
- Co-authors
- Abdurrahman IşıkdoğanKaplan MaZuhat UrakçıMehmet KüçükönerKenan SağlamAbdullah TaşlıpınarUğur MuşabakZeki Yeşilova
- Journals
- Journal of Clinical Oncology (3 papers)Clinical & Experimental Immunology (2 papers)Clinical Rheumatology (2 papers)Medical Oncology (2 papers)Tumor Biology (2 papers)
- Partner nations
- TürkiyeSerbiaUnited States
In The Last Decade
Ali̇ İnal
90 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 103
- Oncology 290
- Immunology 199
- Pulmonary and Respiratory Medicine 281
- Rheumatology 107
- Reproductive Medicine 50
Countries citing papers authored by Ali̇ İnal
This map shows the geographic impact of Ali̇ İnal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali̇ İnal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali̇ İnal more than expected).
Fields of papers citing papers by Ali̇ İnal
This network shows the impact of papers produced by Ali̇ İnal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali̇ İnal. The network helps show where Ali̇ İnal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ali̇ İnal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2015 | 5 | |
| 4 | 2015 | 10 | |
| 5 | 2014 | 15 | |
| 6 | 2014 | 7 | |
| 7 | 2014 | 5 | |
| 8 | 2014 | 12 | |
| 9 | 2014 | 2 | |
| 10 | Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study. | 2013 | 2 |
| 11 | 2013 | 4 | |
| 12 | 2012 | 3 | |
| 13 | 2012 | 9 | |
| 14 | 2012 | 4 | |
| 15 | 2010 | 3 | |
| 16 | 2009 | 1 | |
| 17 | Bitki besleme ve gübreleme | 2007 | 8 |
| 18 | 2002 | 24 | |
| 19 | 2000 | 15 | |
| 20 | 1991 | 0 |
About Ali̇ İnal
Ali̇ İnal is a scholar working on Transplantation, Oncology, Pulmonary and Respiratory Medicine, Reproductive Medicine and Cancer Research, having authored 95 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Research Studies (10 papers), Cancer Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (7 papers), Inflammasome and immune disorders (7 papers), Cancer Genomics and Diagnostics (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (290 citations), Immunology (199 citations), Pulmonary and Respiratory Medicine (281 citations), Rheumatology (107 citations) and Reproductive Medicine (50 citations). Ali̇ İnal has collaborated with scholars based in Türkiye, Serbia and United States. Frequent co-authors include Abdurrahman Işıkdoğan, Kaplan Ma, Zuhat Urakçı, Mehmet Küçüköner, Kenan Sağlam, Abdullah Taşlıpınar, Uğur Muşabak, Zeki Yeşilova, Çağatay Öktenli and Funda Suer. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Experimental Immunology, Clinical Rheumatology, Medical Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.